GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
11.5959 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, PPARA, PTGES |
10.3846 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, TYR |
9.33658 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CA12, CA2, CA7, CACNA1C, CDK6, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, F10, F3, FABP3, FABP4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR7, MAOA, PPARA, TNKS, TNKS2, XDH |
8.50662 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, HSD11B2, HTR5A, PTGES, RELA, TYR |
8.21998 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PTPN1, RELA, TNKS, TNKS2, XDH |
7.98597 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, GBA2, HSD17B3, HTR1A, MAOA, TYR |
7.98597 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PTPN1, RELA, TNKS, TNKS2, XDH |
7.98597 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A |
7.84967 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, BCL2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, HTR5A, PPARA, PTGES, RELA, TYR |
7.7895 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
7.47173 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FUT7, GBA2, HSD17B3, HTR2B, PPARA, PTGES, TYR, XDH |
6.99154 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.87458 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.87458 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, HTR5A, PTGES, RELA, TYR |
6.86872 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, MAOA, TYR |
6.79864 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AR, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, HTR1A, HTR2A, HTR2B, MAP2K1, PTGES, RELA, XDH |
6.79864 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALPL, APP, AR, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HTR5A, PPARA, PTGES, RELA, TYR |
6.57598 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
6.44142 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AR, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, HSD17B3, MAP2K1, PPARA, RELA, TYR |
6.18636 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
6.0961 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALPL, APP, AR, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HTR2A, HTR2B, HTR5A, PPARA, PTGES, RELA, TYR |
6.03848 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, HTR2A, HTR2B |
5.98543 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PTPN1, RELA, TNKS, TNKS2, XDH |
5.96751 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CYP1B1, DRD2, F10, F3, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PTPN1, RELA, XDH |
5.92817 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.82157 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.77036 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, AR, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, HTR5A, PPARA, RELA |
5.75106 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, CACNA1C, CDK6, DRD1, DRD2, DRD3, HTR2A, HTR2B, TNKS, TNKS2 |
5.6061 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AR, BCL2, CA2, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, GBA2, HSD11B1, HSD17B2, HSD17B3, HTR5A, MAP2K1, PPARA, RELA, SIGMAR1, TYR |
5.54577 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.47867 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A, MAOA |
5.36334 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
5.35135 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.28036 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, MAOA, MAP2K1, MAP3K7, PPARA, PTGES, PTPN1, RELA, TNKS, TNKS2, TYR, XDH |
5.27869 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, APP, AR, BCL2, CA2, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, HSD11B2, HTR5A, PPARA, RELA |
5.1783 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, MAOA |
5.16831 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, HTR1A, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PTPN1, RELA, TNKS, TNKS2, XDH |
5.13186 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES |
5.03787 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, HTR1A, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PTPN1, RELA, TNKS, TNKS2, XDH |
5.02508 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES |
4.94901 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, PPARA, RELA, TNKS2, TYR |
4.94901 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, FABP3, HTR2A, HTR2B |
4.92901 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.90494 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AR, BCL2, CA2, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FUT7, GBA2, HSD11B1, HSD17B2, HSD17B3, HTR2A, HTR2B, HTR5A, MAP2K1, PPARA, RELA, SIGMAR1, TNKS2, TYR |
4.9024 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, AR, BCL2, CYP19A1, ESR1 |
4.84461 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.82978 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES |
4.78798 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.77382 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.77382 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESRRA, F10, F3, FABP4, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PTPN1, RELA, TNKS, TNKS2, XDH |
4.77141 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B |
4.75557 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.74071 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.7183 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD2, FABP3, FABP4, FUT7, GBA2, PPARA, PTGES |
4.64637 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HSD11B2, HTR2A, HTR2B, RELA |
4.51217 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, PPARA, RELA |
4.50805 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FUT7, GBA2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, MAOA, MAP2K1, MAP3K7, PPARA, PTGES, PTPN1, RELA, TNKS, TNKS2, TYR, XDH |
4.50805 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.50805 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.46603 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.46603 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2 |
4.42557 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AR, BCL2, CA1, CA2, CACNA1C, CDK6, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, MAP2K1, MAP3K7, PPARA, PTGES, PTPN1, RELA, SIGMAR1, TNKS, TNKS2 |
4.41324 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
4.38765 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, HTR1A, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PPARA, PTPN1, RELA, TNKS, TNKS2, XDH |
4.37925 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.37925 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.37925 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.35151 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.3402 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, F10, F3, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PTPN1, RELA, XDH |
4.25002 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.21878 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.20048 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
4.19596 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
4.19596 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
4.1607 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, PTGES, RELA |
4.15428 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
4.06329 |
[BP] GO:0007200 |
None
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B |
4.06002 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, APP, AR, BCL2, CDK6, CYP1B1, DRD2, FABP3, MAP2K1, PTGES, XDH |
4.0243 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, TNKS, TNKS2 |
4.01693 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, XDH |
4.01693 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, XDH |
4.01693 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
4.01693 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
4.01693 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, PPARA, PTGES |
3.96511 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
3.93673 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, AR, DRD2, DRD3, HSD11B2, PPARA |
3.93622 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
3.91411 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
3.86763 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AOX1, APP, AR, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, MAOA, MAP3K7, PPARA, RELA, TYR, XDH |
3.85552 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2, HSD11B2 |
3.85552 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES |
3.84392 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
3.84392 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HSD11B2, HTR2A, HTR2B, PPARA, RELA, TYR |
3.83581 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALPL, APP, AR, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F10, F3, FABP3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, MAP2K1, MAP3K7, PPARA, PTGES, PTPN1, RELA, TYR |
3.83581 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, AR, DRD2, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, XDH |
3.80669 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
3.77662 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES |
3.77662 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DRD3, ESR1, F3, HTR1A, HTR2A, HTR2B, RELA |
3.74878 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.73956 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
3.72278 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, FABP3, PPARA |
3.72278 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A6, CYP2D6 |
3.72278 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A6, CYP2D6 |
3.72278 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HTR1A, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PPARA, PTPN1, RELA, TNKS, TNKS2, XDH |
3.67465 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
3.62573 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B |
3.58491 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.53731 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.53731 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, PTGES |
3.51838 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AR, BCL2, CA2, CA7, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HTR1A, HTR2A, HTR2B, MAP2K1, PPARA, PTPN1 |
3.5074 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, MAOA |
3.4974 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, MAOA, MAP2K1, MAP3K7, PPARA, PTGES, PTPN1, RELA, TNKS, TNKS2, TYR, XDH |
3.47531 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.47531 |
[BP] GO:0060402 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
3.47531 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, HTR2A, HTR2B, MAP2K1, MAP3K7, PPARA, PTPN1, XDH |
3.42977 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.39012 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, DRD3, TNKS2 |
3.38963 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, HTR2A, HTR2B, MAP2K1, MAP3K7, PPARA, PTPN1, XDH |
3.38898 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.35453 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.34405 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR2A, HTR2B, MAP2K1, MAP3K7, PPARA, PTPN1, RELA, TNKS, TNKS2, XDH |
3.26905 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, APP, CA2, DRD1, DRD2, DRD3, ESR1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
3.26552 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, GBA2, PPARA, PTGES |
3.26194 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD2, ESRRB, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, XDH |
3.26194 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.25989 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.24765 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
3.22654 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.21157 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, HTR1A, HTR2A |
3.1831 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
3.1662 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
3.1662 |
[BP] GO:0060401 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
3.1662 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.15463 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.15463 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.12454 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, HTR2A, HTR2B, MAP2K1, MAP3K7, PPARA, PTPN1, XDH |
3.09349 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AR, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR2A, HTR2B, MAP2K1, PPARA, PTGES, PTPN1, RELA, TNKS, TNKS2, XDH |
3.09349 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PPARA |
3.05727 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, RELA |
3.05516 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HTR2A, HTR2B, MAP2K1, MAP3K7, PPARA, PTPN1, RELA, TNKS, TNKS2, XDH |
3.03408 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR2A, HTR2B, MAP2K1, MAP3K7, PPARA, PTPN1, RELA, TNKS, TNKS2, XDH |
2.99536 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F10, F3, FABP4, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PPARA, PTPN1, RELA, TNKS, TNKS2, XDH |
2.99085 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.95205 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.95205 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.95205 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, DRD1, DRD2, DRD3, TNKS, TNKS2 |
2.93147 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.93146 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.92226 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, PTGES |
2.91895 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, APP, AR, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, TNKS, XDH |
2.90138 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.90138 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD2, ESR1, ESR2, F3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, RELA, TNKS, XDH |
2.89702 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.87392 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.87392 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, FABP3, PPARA |
2.87216 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.87216 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD2, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, XDH |
2.85609 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.85506 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, HTR2B, HTR5A |
2.85506 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HTR2A, HTR2B, MAP2K1, MAP3K7, PPARA, PTPN1, RELA, TNKS, TNKS2, XDH |
2.82264 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.79429 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.79238 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, MAP2K1, RELA, TYR |
2.78267 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, CSNK2A1, DRD2, ESR1, F3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, RELA, XDH |
2.74948 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, APP, AR, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FABP4, HTR2A, HTR2B, MAP2K1, MAP3K7, PPARA, PTPN1, RELA, TNKS, XDH |
2.74712 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, AR, CACNA1C, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
2.72199 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B |
2.72197 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.72081 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.72081 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.70996 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.70451 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.68674 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA |
2.68674 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.68166 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A, MAOA |
2.65957 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, AR, DRD2, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, XDH |
2.62803 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR2B, MAP2K1, MAP3K7, PPARA, PTGES, PTPN1, RELA, TNKS, TNKS2, TYR, XDH |
2.61834 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.5782 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.5782 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AR, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
2.57426 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.57426 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, MAP2K1 |
2.56609 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.56392 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.56392 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, PPARA |
2.56053 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, APP, AR, BCL2, CA2, CACNA1C, CDK6, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, HTR2A, HTR2B, MAP2K1, MAP3K7, RELA, TNKS2, XDH |
2.54374 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.53128 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.53128 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.53128 |
[BP] GO:0048608 |
reproductive structure development
|
AR, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, MAP2K1 |
2.52989 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.5279 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, HSD17B2, HSD17B3, MAP2K1 |
2.51755 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.51755 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, MAP2K1, PTPN1 |
2.49793 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3 |
2.4977 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CACNA1C, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3 |
2.48521 |
[BP] GO:0051282 |
None
|
CACNA1C, DRD1, DRD2, HTR2A, HTR2B |
2.47762 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.47547 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2D6, MAOA |
2.46767 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, XDH |
2.45362 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, GBA2, MAOA, XDH |
2.44754 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, AR, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
2.44754 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, APP, BCL2, CYP1B1, DRD1, DRD2, DRD3, HSD11B2, HTR1A, HTR2A, HTR2B, HTR7, TYR |
2.43329 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, MAP3K7, RELA |
2.42904 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AR, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESR2, F10, F3, HTR2A, HTR2B, HTR6, MAP2K1, MAP3K7, PTPN1, RELA, TNKS, TNKS2, XDH |
2.42904 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.42904 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.42904 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.42904 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, DRD2, DRD3, ESR1, HTR7, PPARA |
2.42904 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B |
2.42258 |
[BP] GO:0009416 |
response to light stimulus
|
APP, BCL2, DRD1, DRD2, DRD3, RELA, TYR |
2.42258 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A |
2.41705 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, MAP2K1 |
2.38343 |
[BP] GO:0048589 |
None
|
ADRA1A, APP, AR, BCL2, CYP19A1, ESR1, TNKS2 |
2.36078 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, MAP2K1, PPARA, RELA |
2.3559 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.3559 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD2, ESR1, F3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, TNKS, XDH |
2.33486 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, MAP2K1, PPARA, RELA, TNKS, TNKS2 |
2.33288 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.32731 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.32731 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FUT7, GBA2, HTR1A, HTR2B, MAOA, MAP2K1, MAP3K7, PPARA, PTPN1, RELA, TNKS, TNKS2, TYR, XDH |
2.32445 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.31627 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.30603 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.30388 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.30388 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.30388 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.28539 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.28539 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, MAP2K1, PPARA, RELA, TNKS, TNKS2 |
2.26464 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.25063 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, PPARA |
2.24579 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AR, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, PTPN1, RELA, XDH |
2.24532 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, AR, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, PTPN1, RELA, XDH |
2.2323 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.22217 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HSD17B3 |
2.20783 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, GBA2, MAOA, XDH |
2.20144 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3 |
2.20144 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.19467 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AR, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR2A, HTR2B, MAP2K1, PPARA, PTGES, PTPN1, RELA, TNKS, TNKS2, XDH |
2.19358 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.19194 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, HSD11B2, RELA |
2.17839 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3 |
2.17067 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, AR, BCL2, CDK6, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, PPARA, PTPN1, RELA, XDH |
2.15795 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3 |
2.14974 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, BCL2, CA2, CA7, CACNA1C, CYP19A1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, MAP2K1, PPARA, PTPN1 |
2.14497 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.12545 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.12545 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.12545 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.12545 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.12545 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.12545 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.12545 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.12545 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.12545 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, HTR2A |
2.12397 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, ESR1, HSD17B3 |
2.12397 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.12397 |
[BP] GO:0051302 |
None
|
CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.0967 |
[BP] GO:0007568 |
aging
|
ADRA1A, BCL2, CYP1A1, HTR2A, MAP2K1, RELA |
2.07743 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, GBA2, PPARA, PTGES, TYR |
2.07163 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, BCL2, CACNA1C, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, MAP2K1, MAP3K7, PTPN1, RELA |
2.05188 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR2A, PPARA |
2.05118 |
[BP] GO:0040007 |
None
|
ADRA1A, APP, AR, BCL2, CYP19A1, ESR1, TNKS2 |
2.05118 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD2, ESR1, F3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, XDH |
2.04603 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, MAP2K1, TNKS |
2.04603 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A |
2.04603 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A |
2.04603 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, APP, AR, BCL2, CA2, CYP1B1, DRD2, DRD3, ESRRB, F3, HTR2A, HTR2B, MAP2K1, MAP3K7, RELA |
2.03899 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HTR2A, MAP2K1, PPARA, PTPN1, RELA, TNKS, TNKS2 |
2.0287 |
[BP] GO:0045777 |
None
|
ADORA1, ADRA1A, HSD11B2 |
2.00803 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.00803 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX5, ALPL, APP, AR, BCL2, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, MAOA, MAP2K1, MAP3K7, PTGES, PTPN1, SIGMAR1, TNKS, TNKS2, TYR |
4.76511 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, F10, GBA2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTGES, PTPN1, SIGMAR1 |
4.43321 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AR, BCL2, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F10, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR2A, HTR5A, MAOA, MAP2K1, MAP3K7, PTGES, PTPN1, RELA, SIGMAR1, TNKS, TNKS2, TYR, XDH |
4.21878 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTGES, SIGMAR1 |
4.21878 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.53731 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, BCL2, CA12, CA14, CA2, CA4, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, MAOA, PTGES, PTPN1, SIGMAR1, TYR |
3.41306 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, CA4, DRD1, DRD2, DRD3, F10, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
3.21157 |
[CC] GO:0005783 |
None
|
ADORA1, APP, BCL2, CA4, CYP19A1, CYP2D6, GBA2, HSD17B3, HTR5A, MAP2K1, PTPN1, SIGMAR1, XDH |
2.87392 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.47547 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AR, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F10, F3, GBA2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, MAP2K1, MAP3K7, PTPN1 |
2.19467 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, PPARA, PTPN1, TNKS, TYR, XDH |
9.74547 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
8.10068 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MAP2K1, MAP3K7, PPARA, PTGES, PTPN1, RELA, TNKS, TNKS2, TYR, XDH |
7.98597 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
7.98597 |
[MF] GO:0008227 |
None
|
ADRA1A, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.65407 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
7.58911 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MAP3K7, PPARA, PTPN1, TNKS, TNKS2, TYR, XDH |
7.43702 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.95493 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.87458 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.87458 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.86872 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.86872 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6 |
6.74064 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, SHBG |
6.5096 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, XDH |
6.3212 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
5.82157 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, XDH |
5.79734 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.29611 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AR, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, PPARA, SIGMAR1 |
5.28036 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
5.25443 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
5.25443 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AR, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, MAP2K1, MAP3K7, PPARA, SIGMAR1 |
5.16831 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
5.13186 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
5.01916 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.00936 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, TYR |
5.00062 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AR, CDK6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, PPARA, SIGMAR1 |
5.00062 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.90494 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.87871 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AR, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, PPARA, SIGMAR1 |
4.61107 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.46603 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.37925 |
[MF] GO:0008289 |
lipid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, SHBG |
4.19042 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.11018 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, F10, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, MAP2K1, MAP3K7, PTGES, PTPN1, TNKS, TNKS2, TYR, XDH |
4.06906 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, HSD11B2, HSD17B1, PTGES, XDH |
4.00371 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, TYR |
3.84392 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, PPARA, PTPN1, TNKS |
3.4534 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6 |
3.24299 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A6, CYP2D6 |
3.2069 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
3.16737 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6 |
3.09087 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.04704 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AR, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, MAP3K7, PPARA, PTPN1, TNKS, TNKS2, TYR, XDH |
2.95205 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.95205 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.92226 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.92226 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.84036 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.54948 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.511 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.47547 |
[MF] GO:0008144 |
drug binding
|
ACHE, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, HTR2A, HTR2B, MAP2K1, MAP3K7, PPARA, SIGMAR1 |
2.46767 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
2.33628 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, F3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
2.33628 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.30388 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.30388 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.12545 |